Lindbrook Capital, LLC - TRACON PHARMACEUTICALS INC ownership

TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 46 filers reported holding TRACON PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.76 and the average weighting 0.1%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of TRACON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$8,000
-57.9%
2,000
-33.3%
0.00%
-50.0%
Q2 2021$19,000
-64.2%
3,000
-53.8%
0.00%
-66.7%
Q1 2021$53,000
+1.9%
6,500
-35.0%
0.01%
-14.3%
Q3 2020$52,00010,0000.01%
Other shareholders
TRACON PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Opaleye Management Inc. 4,764,508$848,0820.28%
Ikarian Capital, LLC 2,765,530$492,2650.06%
JOHNSON & JOHNSON 84,003$14,9530.01%
BOOTHBAY FUND MANAGEMENT, LLC 258,844$46,0740.00%
BlackRock Inc. 267,821$47,6730.00%
Bank of New York Mellon Corp 10,259$1,8260.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 15,835$2,8190.00%
Truvestments Capital LLC 318$570.00%
Tower Research Capital LLC (TRC) 10,407$1,8520.00%
Cutler Group LLC / CA 1,200$00.00%
View complete list of TRACON PHARMACEUTICALS INC shareholders